The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. After-hours trades for Biodesix Inc. (BDSX) shows that investor sentiment remained intact, with the stock’s consolidated last price rising by $0.21, or 9.13%, to $2.51. The Biodesix Inc. has recorded 3,643 volume in the after hours trading session. Earlier, Yahoo Finance discussed this stock as it revealed Biodesix Announces First Four Private Payer Coverage Policies for the Nodify XL2® Test.
Biodesix Inc. is listed on the NASDAQ as a member of the Healthcare sector and is a part of the Diagnostics & Research industry. At the end of the last regular session, the stock closed at $2.30 and fluctuated between $2.4404 as its day high and $2.0100 as its day low. The current market capitalization of Biodesix Inc. is $144.09M. A total of 0.29 million shares were traded on the day, compared to an average of 200.47K shares.
Additionally, investors take into account insider trades when predicting how a stock will perform. During the recent three months, BDSX has seen 19 BUY and 12 SELL insider trades, representing the acquisition of 12,500,871 and the disposition of 24,145 shares. Over the last 12 months, there were 37 BUYs and 24 SELLs from insiders. Insiders purchased 16,313,876 shares during that period but sold 71,482.
In the most recent transaction, SCHULER JACK W bought 10,000 shares of BDSX for 1.70 per share on Dec 16. After the transaction, the Director now owns 20,339,189 company shares. In a previous transaction on Dec 15, SCHULER JACK W bought 20,000 shares at 1.65 per share. BDSX shares that Director owns now total 20,329,189.
Among the insiders who bought shares, SCHULER JACK W acquired of 189,675 shares on Dec 14 at a per-share price of $1.65. This resulted in the Director holding 20,309,189 shares of BDSX after the transaction. In another insider transaction, SCHULER JACK W bought 67,402 shares at $1.58 per share on Dec 13. Company shares held by the Director now total 20,119,514.
Though price targets are rarely accurate, they can exert some influence from time to time and were often accepted as valuable by the market. According to analysts who have offered 12-month price targets for BDSX in the last 3 months, the mean price target is $5.00 with high estimates of $5.00 and low estimates of $5.00. In terms of 52-week highs and lows, BDSX has a high of $6.00 and a low of $0.95.
As of this writing, BDSX has an earnings estimate of -$0.33 per share for the current quarter. EPS was calculated based on a consensus of 4 estimates, with a high estimate of -$0.31 per share and a lower estimate of -$0.36. The company reported an EPS of -$0.5 in the last quarter, which was -25.00% lower than expectations of -$0.4.
Balance Sheet Annually/Quarterly
A balance sheet is a report that shows the company’s assets and liabilities. In addition, it shows how much equity investors have invested in the company. Investors can determine the company’s prospects by calculating its financial ratios based on this information.
It may be riskier to trade before market opening and after market closing than during regular market hours. Since issuers often announce critical financial information outside regular trading hours. Extended-hours trading may result in wider spreads for particular securities due to lower liquidity and higher volatility. Currently, 4 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for BDSX is Buy with a score of 4.33. A total of 3 analysts rated the stock as Buy while 0 rated it as Overweight while 1 rated it as Hold. Among the other participants, 0 thought the stock was Underweight and 0 thought it should be Sold.